“…The clinical benefits of enhanced external counterpulsation (EECP) therapy in chronic stable refractory angina patients who fail to respond to conventional treatment, such as percutaneous coronary intervention or bypass surgery combined with aggressive antiangina medication, include reductions in myocardial ischemia, angina episodes, and nitrate use (1) and improvement in exercise tolerance (1)(2)(3), erectile function (4), and quality of life (5,6). Furthermore, the most recent report from the International EECP Patient Registry…”